It is a pharma private limited company based in Gujvail, Telangana, India, established in 2019.
2019 | Gujvail, Telangana, India | Converted to LLPExarmed Pharma Private Limited, a converted to llp private limited company, was established on 08 January 2019 in Gujvail, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24110TG2019PTC129565. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹13.50 Cr and a paid-up capital of ₹13.50 Cr.
It upholds a compliant status. Its leadership includes Bala Murali Krishna Thippabhotla (Director), Jahnavi Puchakayala (Director), Vajrala Bhulakshmi (Director). Past directors included Bala Murali Krishna Thippabhotla. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Survey 321, Plot No. 55/A, Biotech Park, Phase Iii Tsiic, Karakapatla Village, Markook Mandal, Siddipet District, Telangana 502281, Gujvail, Telangana, 502281.
U24110TG2019PTC129565
129565
08 January 2019
₹13.50 Cr
₹13.50 Cr
Roc Hyderabad
Unlisted
Converted to LLP
Explore comprehensive insights into Exarmed Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bala Murali Krishna Thippabhotla | Director | 01 Jul 2019 | Current |
| Jahnavi Puchakayala | Director | 08 Jan 2019 | Current |
| Vajrala Bhulakshmi | Director | 08 Jan 2019 | Current |
| Madhusudhan Reddy | Company Secretary | 01 Nov 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Exarmed Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 109.07% increase. The company also saw a substantial improvement in profitability, with a 358.57% increase in profit. The company's net worth moved up by a moderate rise of 0.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Exarmed Pharma had a promoter holding of 65.79% and a public holding of 34.21%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Exarmed Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Exarmed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exarmed Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Exarmed Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Exarmed Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was completed.
The activity Madhusudhan Reddy was appointed as a Company Secretary was appointed as a Company Secretary on 01 Nov 2022 & has been associated with this company since 3 years 29 days . was completed.
The activity Ganamoor Madhusudhan Reddy was appointed as a Company Secretary was appointed as a Company Secretary on 01 Nov 2022 & has been associated with this company since 3 years 29 days . was completed.
Bala Murali Krishna Thippabhotla was appointed as a Director was appointed as a Director on 01 Jul 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
Progress on Jahnavi Puchakayala was appointed as a Director was appointed as a Director on 08 Jan 2019 & has been associated with this company since 6 years 10 months . was documented.
The CIN of Exarmed Pharma Private Limited is U24110TG2019PTC129565.
Exarmed Pharma Private Limited is headquartered at Survey 321, Plot No. 55/A, Biotech Park, Phase Iii Tsiic, Karakapatla Village, Markook Mandal, Siddipet District, Telangana 502281, Gujvail, Telangana, 502281.
Exarmed Pharma Private Limited was incorporated on 08 January 2019.
The current directors of Exarmed Pharma Private Limited are
The primary industry of Exarmed Pharma Private Limited is Manufacturing.
Exarmed Pharma Private Limited is unlisted.
The authorized capital of Exarmed Pharma Private Limited is ₹13.50 Cr, and the paid-up capital is ₹13.50 Cr.
The compliance status of Exarmed Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX